10.1016/S2213-8587(19)30422-X Summary Keywords GLP-1 receptor agonists, diabetes, coronary artery disease, acute and chronic coronary syndromes, atherosclerosis, coronary microcirculation Citation Pahud de Mortanges A, Sinaci E, Salvador Jr D, Bally L, Muka T, Wilhelm M and Bano A (2022) GLP-1 Receptor Agonists and Coronary Arteries: From Mechanisms to Events
H.LiJ.et al (2023)
She is knowledgeable and took a lot of time with me to help me achieve my goals
Major carriers often provide benefits for FDA-approved weight loss drugs, including options like Wegovy and Zepbound
The involvement of PLC- in OA-stimulated PI hydrolysis was examined using PLC- siRNA
New aspects in probucol cardioprotection against doxorubicin-induced cardiotoxicity